Cimpress Plc SEC Filings

Cimpress plc director Dessislava Temperley reported restricted share unit (RSU) vesting and related share transactions. On 11/15/2025, RSUs vested and were exercised into 351, 1,128, 494, and 638 ordinary shares at an exercise price of $0 per share, increasing her direct holdings. On the same date, she disposed of 1,256 ordinary shares at $66.59 per share. Following these transactions, she directly beneficially owned 4,285 Cimpress ordinary shares, and continues to hold additional unvested or unexercised RSUs as shown in the derivative securities table.

Cimpress plc (CMPR) director Sophie Gasperment reported equity transactions on 11/15/2025 involving the vesting of restricted share units (RSUs) and a share sale. Several RSU awards vested and converted into ordinary shares, including 351, 1,128, 494 and 638 ordinary shares, each at an exercise price of $0 as these are RSUs rather than options. Following these transactions, she continued to hold ordinary shares directly.

The filing also shows a disposition of 1,256 ordinary shares coded “F” at a price of $66.59, typically indicating shares withheld or sold to cover taxes associated with the vesting. The RSU awards referenced in Table II vest over four years, with 25% of the original RSU grant vesting on the initial vesting date and another 25% vesting each year thereafter.

Cimpress plc CEO, Chairman and Director Robert S. Keane reported equity award activity involving performance share units (PSUs). On 11/15/2025, three PSU awards vested and were settled in ordinary shares, delivering 9,579, 146 and 3,388 ordinary shares at an exercise price of $0 per share. To cover related obligations, 5,404 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly owned 65,092 ordinary shares. He also reported substantial indirect holdings through several entities, including 220,503 shares via the Keane Family Foundation and 986,785 shares via Third Delaware 2011, LLC.

Cimpress plc executive vice president and chief technology officer Maarten Wensveen reported equity transactions in the company’s ordinary shares on 11/15/2025. Several awards of restricted share units and performance share units were exercised at an exercise price of $0, resulting in acquisitions of 1,860, 3,697, and 1,303 ordinary shares as those units vested. On the same date, 3,319 ordinary shares were disposed of at a price of $66.59 per share. Following these transactions, Wensveen directly beneficially owned 24,128 Cimpress ordinary shares.

Cimpress plc (CMPR) executive Sean E. Quinn reported equity award activity on a Form 4. On 11/15/2025, Quinn, the company’s EVP and Chief Financial Officer, exercised vested restricted share units (RSUs) and performance share units (PSUs), each representing the right to receive one ordinary share upon vesting.

The filing shows multiple “M” transactions in which RSUs and PSUs converted into ordinary shares at an exercise price of $0, and one “F” transaction in which 4,121 ordinary shares were disposed of at $66.59 per share. After these transactions, Quinn directly owned 40,883 ordinary shares and continued to hold additional RSUs and PSUs that vest over a four-year period, with 25% vesting on the listed exercisable dates and 6.25% vesting quarterly thereafter.

Cimpress plc executive reports share vesting and sale activity. On 11/15/2025, EVP and CEO, Vista, Florian Baumgartner acquired 1,691 ordinary shares from vested restricted share units and 3,550 and 1,303 ordinary shares from vested performance share units, all at an exercise price of $0. On the same date, 3,108 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly beneficially owned 59,867 Cimpress ordinary shares, along with outstanding restricted share units and performance share units that continue to vest over a four-year schedule.

Cimpress plc (CMPR) reported an insider buy by its EVP, Chief Financial Officer, Sean E. Quinn. On 11/06/2025, Quinn executed multiple open‑market purchases totaling 4,000 ordinary shares at prices ranging from $61.83 to $63.00.

Following these transactions, Quinn beneficially owned 36,484 ordinary shares, held directly, as reflected after each reported trade.

Cimpress plc (CMPR) — Form 4 insider sale: EVP & Chief Technology Officer Maarten Wensveen sold Cimpress ordinary shares on 11/03/2025. Reported sales were 21,010 shares at a weighted-average price of $68.24, 1,294 shares at $69.30, and 526 shares at $70.74. The prices reflect weighted averages within disclosed ranges. Following these transactions, he beneficially owned 20,587 shares, held directly.

The filing notes price ranges for each trade: $67.98–$68.97, $68.99–$69.95, and $70.02–$70.93, and states that detailed price-by-size information will be provided upon request.

Cimpress plc reported stronger results for the three months ended September 30, 2025. Revenue rose to $863.3 million from $805.0 million, driven by growth at Vista and PrintBrothers. Operating income increased to $49.0 million from $39.3 million. Net income attributable to Cimpress was $7.6 million versus a loss of $12.5 million a year ago, with diluted EPS of $0.30 compared to $(0.50).

Adjusted EBITDA reached $98.7 million, up $10.9 million, while cash from operations improved to $25.1 million. Vista delivered $454.9 million of segment revenue, PrintBrothers $184.7 million, National Pen $103.2 million, and The Print Group $96.7 million. The company ended the quarter with cash of $200.5 million and total debt outstanding, net, of $1.58 billion. Interest expense was $28.1 million. Capital investments continued with $26.4 million in property, plant and equipment and $17.3 million in capitalized software, supporting production capacity and the mass customization platform.